Advertisement

Vitiligo pp 429-435 | Cite as

Photoprotection Issues

  • Alessia Pacifico
  • Giovanni LeoneEmail author
  • Mauro Picardo
Chapter

Abstract

A number of mechanisms have been developed during evolution to protect human skin from excessive UV radiation. To classify the susceptibility of human subjects to develop erythema following UV exposure, Fitzpatrick’s system differentiates six sun-reactive skin phototypes (SPT) [1] (Table 41.1). In this system, the capacity to tan is equally important to help to categorize individuals of any colour or ethnic background. Using this method, the physician can estimate the relative risk of developing acute and chronic changes related to UV exposure. A study by Carrettero-Mangolis and Lim confirms that there is a correlation between minimal erythema dose (MED) and SPT, i.e. the higher the SPT, the higher the MED [2].

References

  1. 1.
    Fitzpatrick TB. The validity and practicality of sunreactive skin types I through VI. Arch Dermatol. 1988;124:869–71.CrossRefGoogle Scholar
  2. 2.
    Carretero-Magolis C, Lim HW. Correlation between skin types and minimal erythema dose in narrow band UVB (TL-01) phototherapy. Photodermatol Photoimmunol Photomed. 2001;17:244–6.CrossRefGoogle Scholar
  3. 3.
    Pathak MA, Fitzpatrick TB. The role of natural photoprotective agents in human skin. In: Pathak MA, Harber LC, Seljl M, Kukita A, editors. Sunlight and man, normal and abnormal photobiologic responses. Tokyo: University of Tokyo Press; 1974. p. 725–50.Google Scholar
  4. 4.
    Kaidbay KH, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin-a comparison of black and Caucasian skin. J Am Acad Dermatol. 1979;1:249–60.CrossRefGoogle Scholar
  5. 5.
    McFadden AW. Skin disease in the Cuna Indians. Arch Dermatol. 1961;84:1013–23.CrossRefGoogle Scholar
  6. 6.
    Taylor CR, Stern RS, Leyden JJ, Gilchrest BA. Photoaging/photodamage and photoprotection. J Am Acad Dermatol. 1990;22:1–15.CrossRefGoogle Scholar
  7. 7.
    Cario-André M, Pain C, Gall Y, et al. Studies on epidermis reconstructed with and without melanocytes: melanocytes prevent sunburn cell formation but not appearance of DNA damaged cells in fair skinned Caucasians. J Invest Dermatol. 2000;115:193–9.CrossRefGoogle Scholar
  8. 8.
    Yamaguchi Y, Beer JZ, Hearing VJ. Melanin mediated apoptosis of epidermal cells damaged by ultraviolet radiation: factors influencing the incidence of skin cancer. Arch Dermatol Res. 2008;300:s43–50.CrossRefGoogle Scholar
  9. 9.
    Gniadecka M, Wulf HC, Mortensen NN, Poulsen T. Photoprotection in vitiligo and normal skin. A quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation. Acta Derm Venereol. 1996;76:429–32.PubMedGoogle Scholar
  10. 10.
    Sheehan JM, Potten CS, Young AR. Tanning in human skin types II and III offers modest photoprotection against erythema. Photochem Photobiol. 1998;68:588–92.CrossRefGoogle Scholar
  11. 11.
    Kaidbay KH, Kligman AM. Sunburn protection by longwave ultraviolet radiation induced pigmentation. Arch Dermatol. 1978;114:46–8.CrossRefGoogle Scholar
  12. 12.
    Hamzavi I, Deleon S, Yue K, Murakawa G. Repigmentation does not affect tolerance to NB UVB light in patients with vitiligo. Photodermatol Photoimmunol Photomed. 2004;20:117.Google Scholar
  13. 13.
    Oh C, Hennessy A, Ha T, et al. The time course of photoadaptation and pigmentation studies using a novel method to distinguish pigmentation from erythema. J Invest Dermatol. 2004;123:965–72.CrossRefGoogle Scholar
  14. 14.
    Caron-Schreinemachers ALDB, Kingswijk MM, Bos JD, Westerhof W. UVB 311 nm tolerance of vitiligo skin increases with skin photo type. Acta Derm Venereol. 2005;85:24–6.CrossRefGoogle Scholar
  15. 15.
    Bessou-Touya S, Picardo M, Maresca V, et al. Chimeric human epidermal reconstructs to study the role of melanocytes and keratinocytes in pigmentation and photoprotection. J Invest Dermatol. 1998;111:1103–8.CrossRefGoogle Scholar
  16. 16.
    Picardo M, Maresca V, Eibenschutz L, et al. Correlation between antioxidants and phototypes in melanocytes cultures. A possible link of physiologic and pathologic relevance. J Invest Dermatol. 1999;113:424–5.CrossRefGoogle Scholar
  17. 17.
    Dumaz N, van Kranen HJ, de Vries A, et al. The role of UVB light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis. 1997;18:897–904.CrossRefGoogle Scholar
  18. 18.
    Madan V, Hoban P, Strange RC, et al. Genetics and risk factors for basal cell carcinoma. Br J Dermatol. 2006;154(Suppl 1):5–7.CrossRefGoogle Scholar
  19. 19.
    Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol. 2001;44:837–46.CrossRefGoogle Scholar
  20. 20.
    De Fabo EC, Noonan FP, Fears T, Merlino G. Ultraviolet B but not Ultraviolet A radiation initiates melanoma. Cancer Res. 2004;64:6372–6.CrossRefGoogle Scholar
  21. 21.
    Lim HW, Naylor M, Honigsman H, et al. American Academy of Dermatology consensus conference on UVA protection of sunscreens: summary and recommendations. J Am Acad Dermatol. 2001;44:505–8.CrossRefGoogle Scholar
  22. 22.
    Morison WL. Clinical practice. Photosensitivity. N Engl J Med. 2004;350:1111–7.CrossRefGoogle Scholar
  23. 23.
    Calanchini-Postizzi E, Frank E. Long term actinic damage in sun exposed vitiligo and normally pigmented skin. Dermatologica. 1987;174:266–71.CrossRefGoogle Scholar
  24. 24.
    Schallreuter KU, Behrens-Williams S, Khaliq TP, et al. Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol. 2003;12:268–77.CrossRefGoogle Scholar
  25. 25.
    Buljan M, Situm M, Lugovic L, Vucic M. Metastatic melanoma and vitiligo: a case report. Acta Dermatovenerol Croat. 2006;14:100–3.PubMedGoogle Scholar
  26. 26.
    Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med. 2006;354:709–18.CrossRefGoogle Scholar
  27. 27.
    Michail M, Wolchock J, Goldberg SM, et al. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. Arch Dermatol. 2008;144:560–1.Google Scholar
  28. 28.
    Halder RM, Brooks HL. Medical therapies for vitiligo. Dermatol Ther. 2001;14:1–6.CrossRefGoogle Scholar
  29. 29.
    Palm MD, O’Donoghue MN. Update on photoprotection. Dermatol Ther. 2007;20:360–76.CrossRefGoogle Scholar
  30. 30.
    Paro Vidolin A, Barbieri, L, Aurizi C, Marcassoli LG, Leone G. Photoprotection in vitiligo patients: a new approach. Poster n. 13 Abstracts of the Vitiligo International Symposium (VIS), Detroit, 2018;9–10.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Alessia Pacifico
    • 1
  • Giovanni Leone
    • 1
    Email author
  • Mauro Picardo
    • 2
  1. 1.Phototherapy UnitSan Gallicano Dermatological Institute, IFORomeItaly
  2. 2.Cutaneous Physiopathology and CIRMSan Gallicano Dermatological Institute, IRCCSRomeItaly

Personalised recommendations